SCHEMBL28818445

SCHEMBL28818445

O=CN1CCC(c2ccc(O)cc2)CC1

nearest known ligand 0.55

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ ESR2 Q92731 10/20 0.55
▸ ESR1 P03372 1/20 0.46
▸ CYP3A4 P08684 1/20 0.46
▸ CYP2C9 P11712 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3710421 0.82 SLC18A3 (0.52) CYP2C9
SCHEMBL16994794 0.81 SLC18A3 (0.49) —
SCHEMBL19971165 0.81 ATM (0.44) —
SCHEMBL21285985 0.81 SLC18A3 (0.49) —
SCHEMBL7854565 0.81 SIGMAR1 (0.51) —
SCHEMBL6826830 0.78 TP53 (0.48) —
SCHEMBL28818482 0.77 DRD2 (0.56) —
SCHEMBL22688514 0.77 P2RY14 (0.57) —
SCHEMBL4402425 0.77 TP53 (0.48) —
SCHEMBL29067326 0.77 TRIM24 (0.49) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114901640-A Novel compounds useful for the treatment of dyslipidemia 兹杜斯生命科学有限公司 2022-08-12 — — CN claimed
CN-116529252-A Prodrugs for sustained release of therapeutic agents and uses thereof 重庆两江药物研发中心有限公司 2023-08-01 — — CN disclosed
CN-114901640-A Novel compounds useful for the treatment of dyslipidemia 兹杜斯生命科学有限公司 2022-08-12 — — CN disclosed
Send feedback